Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZBTB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CTNS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CBR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B4GALT5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C10orf10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DFFA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYLIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXorf40B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM185A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COQ4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on